βIII-tubulin regulates breast cancer metastases to the Brain

Molecular Cancer Therapeutics

Volumn 14, Issue 5, 2015, Pages 1152-1161

  Kanojia, Deepak ^a   Morshed, Ramin A ^a   Zhang, Lingjiao ^a   Miska, Jason M ^a   Qiao, Jian ^a   Kim, Julius W ^a   Pytel, Peter ^a   Balyasnikova, Irina V ^a   Lesniak, Maciej S ^a   Ahmed, Atique U ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA III TUBULIN; BETA TUBULIN; BETA3 INTEGRIN; FOCAL ADHESION KINASE; NESTIN; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; TUBB3 PROTEIN, HUMAN; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; EXTRACELLULAR MATRIX; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS POTENTIAL; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN TUMOR; BREAST TUMOR; CANCER TRANSPLANTATION; GENETICS; METABOLISM; PATHOLOGY; SECONDARY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

ANIMALS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; TUBULIN; UP-REGULATION;

EID: 84942162796     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-14-0950     Document Type: Article

References (39)

1. Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK. The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol 2011;8:344-56.
2. Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 2011;11:352-63.
3. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009;459:1005-9.
4. Sihto H, Lundin J, Lundin M, Lehtimaki T, Ristimaki A, Holli K, et al. Breast cancer biological subtypes and protein expression predict for the preferential distantmetastasis sites: a nationwide cohort study. Breast Cancer Res 2011;13:R87.
5. Neman J, Termini J, Wilczynski S, Vaidehi N, Choy C, Kowolik CM, et al. Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc Natl Acad Sci U S A 2014;111:984-9.
6. Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014;156:1002-16.
7. Zhang S, Huang WC, Zhang L, Zhang C, Lowery FJ, Ding Z, et al. SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. Cancer Res 2013;73:5764-74.
8. Chiu WT, Lee HT, Huang FJ, Aldape KD, Yao J, Steeg PS, et al. Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res 2011;71:4932-43.
9. Xing F, Kobayashi A, Okuda H, WatabeM, Pai SK, Pandey PR, et al. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol Med 2013;5:384-96.
10. Saldana SM, Lee HH, Lowery FJ, Khotskaya YB, Xia W, Zhang C, et al. Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis. PloS ONE 2013;8:e73406.
11. Nie F, Yang J, Wen S, An YL, Ding J, Ju SH, et al. Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis. Cancer 2012;118:5198-209.
12. Fife CM, McCarroll JA, Kavallaris M. Movers and shakers: cell cytoskeleton in cancer metastasis. Br J Pharmacol 2014;171:5507-23.
13. Luduena RF. Multiple forms of tubulin: different gene products and covalent modifications. Int Rev Cytol 1998;178:207-75.
14. Tischfield MA, Baris HN, Wu C, Rudolph G, Van Maldergem L, He W, et al. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell 2010;140:74-87.
15. Leandro-Garcia LJ, Leskela S, Landa I, Montero-Conde C, Lopez-Jimenez E, Leton R, et al. Tumoral and tissue-specific expression of the major human beta-tubulin isotypes. Cytoskeleton 2010;67:214-23.
16. Gan PP, Pasquier E, Kavallaris M. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer. Cancer Res 2007;67:9356-63.
17. Mariani M, Zannoni GF, Sioletic S, Sieber S, Martino C, Martinelli E, et al. Gender influences the class III and V beta-tubulin ability to predict poor outcome in colorectal cancer. Clin Cancer Res 2012;18:2964-75.
18. Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 2010;10:194-204.
19. Mozzetti S, Ferlini C, Concolino P, Filippetti F, Raspaglio G, Prislei S, et al. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res 2005;11:298-305.
20. Seve P, Dumontet C. Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents? Lancet Oncol 2008;9:168-75.
21. Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q, et al. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFbeta signaling. Oncogene 2012;31:2614-26.
22. Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, Benz CC. A multigene predictor of metastatic outcome in early-stage hormone receptor-negative and triple-negative breast cancer. Breast Cancer Res 2010;12:R85.
23. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, et al. Strong time dependence of the 76-gene prognostic signature for nodenegative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007;13:3207-14.
24. Malin D, Strekalova E, Petrovic V, Deal AM, Al Ahmad A, Adamo B, et al. alphaB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res 2014;20:56-67.
25. Vogetseder A, Thies S, Ingold B, Roth P, Weller M, Schraml P, et al. alphav-Integrin isoform expression in primary human tumors and brain metastases. Int J Cancer 2013;133:2362-71.
26. Shain KH, Yarde DN, Meads MB, Huang M, Jove R, Hazlehurst LA, et al. Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications formicroenvironment influence on tumor survival and proliferation. Cancer Res 2009;69:1009-15.
27. Powell S, Kaizer A, Koopmeiners JS, Iwamoto C, Klein M. High expression of class III beta-tubulin in small cell lung carcinoma. Oncol Lett 2014;7:405-10.
28. RiihimakiM, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer 2014;86:78-84.
29. Pentheroudakis G, Batistatou A, Kalogeras KT, Kronenwett R, Wirtz RM, Bournakis E, et al. Prognostic utility of beta-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study. Breast Cancer Res Treat 2011;127:179-93.
30. Kiefel H, Bondong S, Hazin J, Ridinger J, Schirmer U, Riedle S, et al. L1CAM: a major driver for tumor cell invasion and motility. Cell Adhes Migration 2012;6:374-84.
31. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003;20:203-13.
32. McCarroll JA, Gan PP, Erlich RB, Liu M, Dwarte T, Sagnella SS, et al. TUBB3/betaIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer. Cancer Res 2015;75:415-25.
33. Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol 2014;16:876-88.
34. Seve P, Lai R, Ding K, Winton T, Butts C, Mackey J, et al. Class III betatubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10. Clin Cancer Res 2007;13:994-9.
35. Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, et al. High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Mol Cancer Ther 2012;11:1203-13.
36. Nolte SM, Venugopal C, McFarlane N, Morozova O, Hallett RM, O'Farrell E, et al. A cancer stem cell model for studying brain metastases from primary lung cancer. J Nat Cancer Inst 2013;105:551-62.
37. Pakneshan S, Safarpour D, Tavassoli F, Jabbari B. Brain metastasis from ovarian cancer: a systematic review. J Neuro-Oncol 2014;119:1-6.
38. Sehouli J, Pietzner K, Harter P, Munstedt K, Mahner S, Hasenburg A, et al. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol 2010;21:2201-5.
39. Lin NU, Amiri-Kordestani L, Palmieri D, Liewehr DJ, Steeg PS. CNS metastases in breast cancer: old challenge, new frontiers. Clin Cancer Res 2013;19:6404-18.